Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones

doi:10.1084/jem.182.2.587

This Article

	Full Text (PDF, 1409K)
	Alert me when this article is cited

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Abromson-Leeman, S.
	Articles by Dorf, M. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Abromson-Leeman, S.
	Articles by Dorf, M. E.


Social Bookmarking

	What's this?

ARTICLES

Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones

S Abromson-Leeman, R Bronson and ME Dorf
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

In vivo adoptive transfer of CD4+ T helper cell type 1 clones reactive with autologous myelin basic protein (MBP) may initiate an inflammatory demyelinating disease of the central nervous system called experimental autoimmune encephalomyelitis. Although MBP is also a component of peripheral nervous system (PNS) myelin, previous studies have failed to demonstrate inflammation in the PNS induced by MBP-reactive T cells. Here, we report on two MBP-specific T cell clones that preferentially initiate inflammatory and demyelinating peripheral neuritis when adoptively transferred to syngeneic recipients. The MBP epitope recognized by these clones spans the junction of exons 6 and 7 and, therefore, is present in the 21- and 18.5-kD but not the 14- and 17-kD MBP isoforms, in which exon 5 is spliced to exon 7. The data suggest that MBP may be processed and presented differently in the central nervous system and PNS, and they provide evidence for MBP as a potential target for autoimmune reactions in the PNS.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Murano, M., Xiong, X., Murano, N., Salzer, J. L., Lafaille, J. J., Tsiagbe, V. K. (2006). Latent TGF-{beta}1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis. J. Leukoc. Biol. 79: 140-146 [Abstract] [Full Text]
Ellmerich, S., Mycko, M., Takacs, K., Waldner, H., Wahid, F. N., Boyton, R. J., King, R. H. M., Smith, P. A., Amor, S., Herlihy, A. H., Hewitt, R. E., Jutton, M., Price, D. A., Hafler, D. A., Kuchroo, V. K., Altmann, D. M. (2005). High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model. J. Immunol. 174: 1938-1946 [Abstract] [Full Text]
Abromson-Leeman, S., Bronson, R., Luo, Y., Berman, M., Leeman, R., Leeman, J., Dorf, M. (2004). T-Cell Properties Determine Disease Site, Clinical Presentation, and Cellular Pathology of Experimental Autoimmune Encephalomyelitis. Am. J. Pathol. 165: 1519-1533 [Abstract] [Full Text]
Chen, L. Z., Hochwald, G. M., Huang, C., Dakin, G., Tao, H., Cheng, C., Simmons, W. J., Dranoff, G., Thorbecke, G. J. (1998). Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1. Proc. Natl. Acad. Sci. USA 95: 12516-12521 [Abstract] [Full Text]